Huang Jing, Zhang Pei-Hong, Gao Yu-Huan, Qiu Lu-Gui
State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.
Diagn Cytopathol. 2012 Apr;40(4):346-51. doi: 10.1002/dc.21641. Epub 2011 Apr 6.
Lymphoma of different histologic type can occur in the same patient. Here, we describe a 64-year-old male patient with angioimmunoblastic T-cell lymphoma (AITL) who subsequently developed diffuse large B-cell lymphoma (DLBCL). At the time of initial diagnosis, histologic examination of a left inguinal lymph node of the patient and a monoclonal pattern of TCRβ gene rearrangement showed typical features of AITL, and there was no evidence of a monoclonal B-cell population. Twenty-six months later, he had generalized lymphadenopathy and organs involvement by DLBCL. A monoclonal IgH gene rearrangement proved de novo development of secondary B-cell lymphoma and excluded relapse of a primary composite lymphoma. The in situ hybridization analysis showed Epstein-Barr-encoded RNA (EBER) sporadic positivity in sample collected from AITL but extensive positivity in the immunoblasts collected from DLBCL. Our observation supports the hypothesis that Epstein-Barr virus (EBV) is etiologically related to AITL in this case. Clonal expansion of EBV-associated DLBCL is a secondary event in AITL via EBV infection or reactivation.
不同组织学类型的淋巴瘤可发生于同一患者。在此,我们描述了一名64岁男性患者,其最初诊断为血管免疫母细胞性T细胞淋巴瘤(AITL),随后发展为弥漫性大B细胞淋巴瘤(DLBCL)。初次诊断时,对患者左侧腹股沟淋巴结进行组织学检查及TCRβ基因重排的单克隆模式显示出AITL的典型特征,且无单克隆B细胞群体的证据。26个月后,他出现了全身性淋巴结肿大及DLBCL累及器官。单克隆IgH基因重排证实了继发性B细胞淋巴瘤的新发,并排除了原发性复合淋巴瘤的复发。原位杂交分析显示,从AITL采集的样本中Epstein-Barr编码RNA(EBER)呈散在阳性,而从DLBCL采集的免疫母细胞中呈广泛阳性。我们的观察支持以下假设:在该病例中,Epstein-Barr病毒(EBV)与AITL存在病因学关联。EBV相关DLBCL的克隆性扩增是AITL中通过EBV感染或再激活发生的继发性事件。